Renal Insufficiency, Chronic [clinicaltrials_resource:7cd2638278b3545f0eceec8ba74284b6]
Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [clinicaltrials:NCT00048438]Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [clinicaltrials:NCT00048451]Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing) [clinicaltrials:NCT00048516]Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq [clinicaltrials:NCT00234533]clinicaltrials:NCT00304148Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension [clinicaltrials:NCT00313430]Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention [clinicaltrials:NCT00345501]Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome [clinicaltrials:NCT00356733]clinicaltrials:NCT00379366Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST) [clinicaltrials:NCT00390585]Impact of Screening Patients With HIV for Kidney Disease [clinicaltrials:NCT00392132]Evaluation of a Bioimpedance Method for Determination of Dry Weight in Dialysis Patients [clinicaltrials:NCT00397306]clinicaltrials:NCT00509262A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function [clinicaltrials:NCT00596518]Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency [clinicaltrials:NCT00630708]Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation [clinicaltrials:NCT00717379]Sensitivity and Specificity of NGAL in an Emergency Room Population [clinicaltrials:NCT00786708]Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects [clinicaltrials:NCT00805090]clinicaltrials:NCT00891813Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease [clinicaltrials:NCT01053936]clinicaltrials:NCT01067963Bosutinib In Subjects With Renal Impairment [clinicaltrials:NCT01233882]clinicaltrials:NCT01289548The Incretin Effect in Patients With Kidney Impairment [clinicaltrials:NCT01327378]Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes [clinicaltrials:NCT01351675]Aspirin Response in High Risk Patients With Coronary Artery Disease [clinicaltrials:NCT01383304]clinicaltrials:NCT01485978clinicaltrials:NCT01533545Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes [clinicaltrials:NCT01549769]Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes [clinicaltrials:NCT01551446]clinicaltrials:NCT01624064A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus [clinicaltrials:NCT01655186]Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD) [clinicaltrials:NCT01663103]Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy [clinicaltrials:NCT01665651]clinicaltrials:NCT01711853clinicaltrials:NCT01817699Study on Colonic Fermentation in Chronic Kidney Disease Patients [clinicaltrials:NCT01874210]A Study of LY2409021 in Participants With Different Levels of Kidney Function [clinicaltrials:NCT01929109]clinicaltrials:NCT01975818A Study of LY2928057 in Hemodialysis Participants [clinicaltrials:NCT01991483]
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00042432Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [clinicaltrials:NCT00048438]Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [clinicaltrials:NCT00048451]Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing) [clinicaltrials:NCT00048516]Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis [clinicaltrials:NCT00062699]Role of Chronic Kidney Disease in Cardiovascular Disease [clinicaltrials:NCT00069810]Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium [clinicaltrials:NCT00073710]A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis [clinicaltrials:NCT00081471]Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis [clinicaltrials:NCT00091481]Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis [clinicaltrials:NCT00091975]Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease [clinicaltrials:NCT00093977]Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis [clinicaltrials:NCT00094484]clinicaltrials:NCT00095056Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis [clinicaltrials:NCT00096915]A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD) [clinicaltrials:NCT00097617]Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers [clinicaltrials:NCT00097747]clinicaltrials:NCT00109291Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis [clinicaltrials:NCT00111098]Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis [clinicaltrials:NCT00112008]Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis [clinicaltrials:NCT00116701]Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease [clinicaltrials:NCT00121602]Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism [clinicaltrials:NCT00123461]An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD) [clinicaltrials:NCT00124098]clinicaltrials:NCT00125593START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism [clinicaltrials:NCT00132431]Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists [clinicaltrials:NCT00134797]CRICKET Study, Coronary Calcium Scores in Patients With Chronic Kidney Disease [clinicaltrials:NCT00142636]Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis [clinicaltrials:NCT00146224]Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients [clinicaltrials:NCT00153621]Efficacy of Pentoxifylline on Chronic Kidney Disease [clinicaltrials:NCT00155246]EPO Deep Tank in Dialysis Subjects [clinicaltrials:NCT00156949]Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD) [clinicaltrials:NCT00156962]Hemofiltration for Contrast-Induced Nephropathy [clinicaltrials:NCT00158080]Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease [clinicaltrials:NCT00169923]Active Vitamin D Effect on Left Ventricular Hypertrophy [clinicaltrials:NCT00175149]Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease [clinicaltrials:NCT00184652]Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. [clinicaltrials:NCT00184769]A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD) [clinicaltrials:NCT00189501]Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease [clinicaltrials:NCT00190580]Effect of Cytokines on Growth of Children With Chronic Kidney Failure [clinicaltrials:NCT00194883]
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00042432Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [clinicaltrials:NCT00048438]Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [clinicaltrials:NCT00048451]Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing) [clinicaltrials:NCT00048516]Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis [clinicaltrials:NCT00062699]Role of Chronic Kidney Disease in Cardiovascular Disease [clinicaltrials:NCT00069810]Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium [clinicaltrials:NCT00073710]A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis [clinicaltrials:NCT00081471]Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis [clinicaltrials:NCT00091481]Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis [clinicaltrials:NCT00091975]Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease [clinicaltrials:NCT00093977]Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis [clinicaltrials:NCT00094484]clinicaltrials:NCT00095056Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis [clinicaltrials:NCT00096915]A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD) [clinicaltrials:NCT00097617]Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers [clinicaltrials:NCT00097747]clinicaltrials:NCT00109291Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis [clinicaltrials:NCT00111098]Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis [clinicaltrials:NCT00112008]Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis [clinicaltrials:NCT00116701]Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease [clinicaltrials:NCT00121602]Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism [clinicaltrials:NCT00123461]An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD) [clinicaltrials:NCT00124098]clinicaltrials:NCT00125593START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism [clinicaltrials:NCT00132431]Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists [clinicaltrials:NCT00134797]CRICKET Study, Coronary Calcium Scores in Patients With Chronic Kidney Disease [clinicaltrials:NCT00142636]Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis [clinicaltrials:NCT00146224]Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients [clinicaltrials:NCT00153621]Efficacy of Pentoxifylline on Chronic Kidney Disease [clinicaltrials:NCT00155246]EPO Deep Tank in Dialysis Subjects [clinicaltrials:NCT00156949]Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD) [clinicaltrials:NCT00156962]Hemofiltration for Contrast-Induced Nephropathy [clinicaltrials:NCT00158080]Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease [clinicaltrials:NCT00169923]Active Vitamin D Effect on Left Ventricular Hypertrophy [clinicaltrials:NCT00175149]Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease [clinicaltrials:NCT00184652]Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. [clinicaltrials:NCT00184769]A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD) [clinicaltrials:NCT00189501]Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease [clinicaltrials:NCT00190580]Effect of Cytokines on Growth of Children With Chronic Kidney Failure [clinicaltrials:NCT00194883]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Renal Insufficiency, Chronic [clinicaltrials_resource:7cd2638278b3545f0eceec8ba74284b6]
Bio2RDF identifier
7cd2638278b3545f0eceec8ba74284b6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7cd2638278b3545f0eceec8ba74284b6
identifier
clinicaltrials_resource:7cd2638278b3545f0eceec8ba74284b6
title
Renal Insufficiency, Chronic
@en
type
label
Renal Insufficiency, Chronic [clinicaltrials_resource:7cd2638278b3545f0eceec8ba74284b6]
@en
Renal Insufficiency, Chronic